PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.22%
Revenue growth above 1.5x ENPH's 1.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
401.45%
Positive gross profit growth while ENPH is negative. John Neff would see a clear operational edge over the competitor.
9.96%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
3.07%
Operating income growth under 50% of ENPH's 26.34%. Michael Burry would be concerned about deeper cost or sales issues.
19.72%
Net income growth at 75-90% of ENPH's 24.63%. Bill Ackman would press for improvements to catch or surpass competitor performance.
-40.00%
Negative EPS growth while ENPH is at 21.74%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-37.93%
Negative diluted EPS growth while ENPH is at 22.73%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.07%
Slight or no buybacks while ENPH is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.05%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-68.96%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-175.51%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
6103.75%
10Y revenue/share CAGR above 1.5x ENPH's 20.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
6103.75%
5Y revenue/share CAGR above 1.5x ENPH's 174.77%. David Dodd would look for consistent product or market expansions fueling outperformance.
295.54%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
2525.30%
10Y OCF/share CAGR above 1.5x ENPH's 176.50%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
2525.30%
Positive OCF/share growth while ENPH is negative. John Neff might see a comparative advantage in operational cash viability.
15668.27%
Positive 3Y OCF/share CAGR while ENPH is negative. John Neff might see a big short-term edge in operational efficiency.
358.17%
Below 50% of ENPH's 2178.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
358.17%
5Y net income/share CAGR above 1.5x ENPH's 174.41%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1436.34%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
Below 50% of ENPH's 112.35%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.87%
AR growth well above ENPH's 17.72%. Michael Burry fears inflated revenue or higher default risk in the near future.
31.97%
Inventory growth well above ENPH's 20.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.73%
Asset growth above 1.5x ENPH's 2.34%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.37%
Under 50% of ENPH's 9.32%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
12.52%
Debt growth far above ENPH's 2.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-126.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.